ArticleHuman vaccines & immunotherapeutics2025

From PD-1/PD-L1 to tertiary lymphoid structures: Paving the way for precision immunotherapy in cholangiocarcinoma treatment.

Fang-Ju Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.